INSIGHTS ON CLINICAL TRIAL PARTNERING

CLINICAL TRIAL PARTNERING SOLUTIONS

  • Advancing biologics from start to finish is highly complex and full of challenges, requiring scientific strategies and implementation.

  • Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.

  • Navigating drug safety in the era of innovation-driven medicine

    The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.

  • Source data verification (SDV) is a critical activity within clinical trial monitoring, yet the traditional approach focused on 100% SDV is limited in its ability to quickly identify issues and prevent them from recurring. Rave TSDV (Targeted SDV), unified with Rave EDC, enables CRAs to focus on critical to quality (CtQ) factors identified within risk management activities.

  • A national research network with advanced facilities, expert investigators, and diverse patients to support efficient Phase I–IV trials and speed complex protocols and enrollment.